Search

everythinglearnresearchcommunity

for

Search:↓

Electrospun nanofiber membranes are promising for non-invasive medical uses like tissue repair and health monitoring.

New therapies are being developed that target integrin pathways to treat various diseases.

Geranium pyrenaicum extracts show potential for cancer, antiviral, and enzyme inhibition treatments.

The method effectively predicts new drug uses, including potential COVID-19 treatments.

Bacterial extracellular vesicles could revolutionize regenerative medicine but need safety improvements.

Using existing drugs for new purposes can effectively treat infections resistant to multiple antibiotics.

Biomaterials can improve non-viral gene delivery by enhancing DNA uptake and reducing toxicity.

Cells with active Wnt signaling are less likely to turn into cancer when exposed to a cancer-causing gene.

Oral lichen planus is a chronic disease causing mouth discomfort and sometimes needs immunosuppressive treatment.

The study found specific skin and cell changes in patients with monkeypox, helping diagnose and understand the disease.

Genetic differences affect how people respond to COVID-19.

Targeting amphiregulin may improve treatment for fibrosis and cancer.

Balancing good and harmful microbes is key to healing chronic wounds.

FMH foods may help manage post-acute COVID-19 symptoms safely and easily.

Managing stress and nerve activity can help treat segmental vitiligo and white hair.

Antituberculosis drugs can cause severe skin reactions, requiring careful diagnosis and treatment.

Long COVID sufferers face significant challenges that need more public awareness and support.

Mice with a virus similar to COVID-19 had skin damage, but a special treatment helped repair it.

New CRISPR/Cas9 variants and nanotechnology-based delivery methods are improving cancer treatment, but choosing the best variant and overcoming certain limitations remain challenges.

The main prostate diseases in dogs are benign growth, infections, and cancer, with various treatments ranging from drugs to surgery, but cancer treatments have limited success.

The combined stem cell secretome in the skin care product effectively reduces inflammation and promotes tissue regeneration.

New-onset fibromyalgia after COVID-19 is poorly understood and needs more research.

Post-COVID, many patients experience skin issues like hair loss and herpes reactivation, especially in middle-aged women.

PCOS is linked to chronic low-grade inflammation, but the role of certain infections is unclear.

CRISPR/Cas9 has improved precision and control but still faces clinical challenges.

Syphilis cases and re-infections increased, highlighting the need for ongoing prevention and treatment.

Antiviral drugs, especially daclatasvir, may be a new treatment for a rare skin disease, improving survival and reducing symptoms in mice.

Imiquimod can cause rare skin side effects, some irreversible, and long-term follow-up is important for users.

Efficient delivery systems are needed for the clinical use of CRISPR-Cas9 gene editing.

The document concludes that significant investment in agricultural innovation is necessary to achieve global food security and nutrition.